News

The Revitas revenue management solution allows pharmaceutical manufacturers to minimise the payment of erroneous claims for rebate and administrative fee payments by validating rebate claims for individual prescriptions.

Chronix has opened the laboratory in association with the First Bank & Trust of Brookings, South Dakota and the Area Development Corporation of Brookings, South Dakota. The Brookings

Notice of allowance has been granted to member patents of this family in the US, Japan, India, China, Korea, Mexico, Israel and Australia. BL-1020 is a novel, first

Lodotra is a proprietary, programmed-release formulation of low-dose prednisone and has received regulatory approval in Europe for the treatment of moderate to severe active rheumatoid arthritis (RA) when

The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines.

Mersana Therapeutics has signed a collaboration agreement with Endo Pharmaceuticals to develop next-generation antibody-drug conjugates (ADCs). Under the deal, Endo will pay an upfront fee to Mersana for

PRM-151 (rhPTX-2) is a recombinant form of human Pentraxin-2, an endogenous human protein that treats fibrosis by regulating the monocyte-derived cells. In a Phase 1 clinical study, PRM-151

The implementation of the Mobile Intelligence provides Rottapharm Madaus Portugal with a simple and fast order-gathering system that utilizes an intuitive graphical user interface (GUI) with features perfectly

Williams replaces Conformetrix’s founder scientists, Andrew Almond, who becomes chief technology officer. Before joining Conformetrix, Williams spent over a decade in the city as a healthcare analyst, with